Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
CALL
McKesson
MCK
$97.2B
| $1.51M | ﹤0.01% |
9,600
-23,100
| -71% | -$3.73M |
|
|
IFLN
3677
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$306M
| $1.51M | ﹤0.01% |
84,849
+27,288
| +47% | +$472K |
|
3678
PJT Partners
PJT
$4.38B
| $1.51M | ﹤0.01% |
62,691
+21,073
| +51% | +$543K |
|
3679
PRA Group
PRAA
$672M
| $1.51M | ﹤0.01% |
51,303
-112,423
| -69% | -$3.24M |
|
3680
PUT
Travelers Companies
TRV
$78.7B
| $1.51M | ﹤0.01% |
12,900
-22,400
| -63% | -$2.45M |
|
|
CSS
3681
DELISTED
CSS Industries, Inc.
CSS
| $1.5M | ﹤0.01% |
53,777
+2,097
| +4% | +$56.5K |
|
3682
PUT
Huntsman Corp
HUN
$1.83B
| $1.5M | ﹤0.01% |
112,700
+34,200
| +44% | +$353K |
|
3683
PUT
Ashland
ASH
$3.31B
| $1.5M | ﹤0.01% |
27,798
-25,959
| -48% | -$1.25M |
|
3684
PUT
Myriad Genetics
MYGN
$303M
| $1.49M | ﹤0.01% |
39,900
-600
| -1% | -$22.6K |
|
|
CCEC
3685
Capital Clean Energy Carriers
CCEC
$1.35B
| $1.49M | ﹤0.01% |
67,497
-714,278
| -91% | -$18M |
|
|
CSH
3686
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $1.49M | ﹤0.01% |
38,623
-96,618
| -71% | -$3.15M |
|
|
EMES
3687
DELISTED
Emerge Energy Services LP
EMES
| $1.49M | ﹤0.01% |
+299,968
| New | +$1.22M |
|
|
CS
3688
CALL
DELISTED
Credit Suisse Group
CS
| $1.49M | ﹤0.01% |
105,300
+82,500
| +362% | +$1.31M |
|
3689
CALL
Vertex Pharmaceuticals
VRTX
$121B
| $1.48M | ﹤0.01% |
18,600
+3,700
| +25% | +$335K |
|
|
NNA
3690
DELISTED
Navios Maritime Acquisition Corporation
NNA
| $1.48M | ﹤0.01% |
62,019
-53,388
| -46% | -$1.57M |
|
3691
PUT
Williams-Sonoma
WSM
$29.3B
| $1.48M | ﹤0.01% |
54,000
+13,600
| +34% | +$369K |
|
3692
PUT
Dillards
DDS
$9.65B
| $1.48M | ﹤0.01% |
17,400
+2,500
| +17% | +$187K |
|
|
AVNS
3693
PUT
DELISTED
Avanos Medical
AVNS
| $1.48M | ﹤0.01% |
51,380
-1,224
| -2% | -$32.6K |
|
3694
Innospec
IOSP
$2.14B
| $1.47M | ﹤0.01% |
33,974
-11,157
| -25% | -$515K |
|
|
NDRM
3695
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $1.47M | ﹤0.01% |
104,334
+16,995
| +19% | +$230K |
|
|
HIBB
3696
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.47M | ﹤0.01% |
41,001
-46,836
| -53% | -$1.56M |
|
3697
International Bancshares
IBOC
$4.74B
| $1.47M | ﹤0.01% |
59,659
-581
| -1% | -$13.6K |
|
|
PPL
3698
PUT
PPL Corp
PPL
$26.5B
| $1.47M | ﹤0.01% |
38,600
+9,900
| +34% | +$352K |
|
|
AVNS
3699
CALL
DELISTED
Avanos Medical
AVNS
| $1.46M | ﹤0.01% |
50,912
-1,044
| -2% | -$27.8K |
|
|
JBTM
3700
JBT Marel
JBTM
$6.9B
| $1.46M | ﹤0.01% |
25,934
-78,506
| -75% | -$3.82M |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.